Anthropic delays blockbuster $2trillion IPO after terrifying warnings AI could take over humanity

Anthropic is reportedly delaying its stock market debut to November, after earlier expectations of an October listing, following whistleblower warnings that AI is developing too quickly and could become uncontrollable, the Wall Street Journal reported. Former Anthropic researcher Jacob Coxon resigned and warned that companies including Anthropic and OpenAI were moving too quickly toward increasingly powerful systems, comments that drew more than 100 million views, while Anthropic CEO Dario Amodei and co-founder Jack Clark have called for slower development, shared safety standards and outside scrutiny. Anthropic has also said it blocked several attempts this year to use its AI systems for research that could potentially be used to develop biological weapons.

Anthropic delays blockbuster $2trillion IPO after terrifying warnings AI could take over humanity - READ MORE: Tech guru demands Anthropic is investigated and IPO paused https://www.dailymail.com/yourmoney/article-16120171/trump-david-sacks-anthropic-ipo-delay.html - See more Daily Mail on Google - save us as a Preferred Source https://google.com/preferences/source?q=dailymail.com Anthropic is reportedly pushing back its blockbuster stock market debut to November after whistleblowers warned that the AI was developing too quickly and could become uncontrollable in the future. The Claude maker had previously been expected to pursue a listing as early as October https://www.dailymail.com/yourmoney/article-15865013/anthropic-ai-ipo-stock-market.html , but people familiar with the plans now say November is being considered. The Wall Street Journal reported that the timing is not set in stone and could be pushed back again, including until after the US midterm elections, according to reports. According to reports, the potential delay comes as Anthropic faces a growing backlash over the risks posed by increasingly powerful AI, including warnings from people inside the industry that the technology could eventually become impossible for humans to control. Former Anthropic researcher Jacob Coxon recently resigned and issued a stark warning about the direction of the AI race https://www.dailymail.com/news/article-16121543/Anthropic-says-thwarted-plots-build-biological-weapons-using-AI-whistleblower-warned-tech-end-humanity.html , saying companies including Anthropic and OpenAI were moving too quickly towards increasingly powerful systems. His comments went viral, attracting more than 100 million views, and added to growing fears about whether AI development is moving faster than the safeguards designed to control it. Coxon has warned that AI could potentially pose an existential threat to humanity, with concerns centering on increasingly autonomous systems that could eventually act beyond human control. The warnings have been particularly striking because Anthropic chief executive Dario Amodei has himself called for the industry to slow down the development of increasingly powerful AI models. President Donald Trump has pushed back strongly against any delay https://www.dailymail.com/news/article-16130379/Trump-claims-HES-guardrail-AI-needs-slams-sick-conspiracy-pushing-regulation.html , claiming that he can ensure the safe use of AI in the United States because of his 'high IQ,' while issuing a stark warning over a 'sick conspiracy' about China. 'The only control or “guardrails” that AI needs is a strong and smart High IQ president, and the U.S.A. has that, in spades ' Trump wrote on Truth Social. Anthropic is reportedly pushing back its blockbuster stock market debut to November after whistleblowers warned that the AI was developing too quickly and could become uncontrollable in the future Amodei has argued that AI companies should deliberately reduce the pace at which they improve their most advanced systems so safety measures have time to catch up. He has also called for independent evaluators, shared safety standards and international cooperation. Anthropic co-founder Jack Clark has gone even further https://www.dailymail.com/news/article-16131759/Anthropic-founder-calls-regulations-Trump.html , saying AI companies need common safety standards and outside scrutiny as they race to develop more powerful systems. Clark has warned that the industry has already seen 'warning shots' from AI systems behaving in unexpected ways, arguing that there is a window to act before the risks become more serious. Those concerns are not purely theoretical. Anthropic has said it blocked several attempts this year to use its AI systems for research that could potentially be used to develop biological weapons. The company said some users had tried to get around its safety controls while carrying out biological research, although Anthropic said it could not determine whether the work was for legitimate scientific purposes or something more dangerous. The revelations add to concerns that increasingly capable AI systems could be misused for everything from cyberattacks to biological weapons – even as technology companies race to make their models more powerful. The IPO plans also come as Anthropic faces fresh scrutiny after researcher Jacob Coxon pictured resigned from the company and warned that it and rival OpenAI were moving too quickly towards increasingly powerful AI systems Anthropic boss Dario Amodei has called on the industry to slow down the development of increasingly powerful AI systems because of safety concerns That puts Anthropic in the extraordinary position of preparing for one of the biggest technology flotations in history while its own chief executive is warning that the industry needs to put the brakes on. If it goes ahead, investors could be looking at one of the biggest stock market launches ever, with Anthropic reportedly discussing a valuation of around $2 trillion https://www.dailymail.com/yourmoney/article-16058063/anthropic-ai-stock-market-ipo.html and a potential fundraising haul of up to $100 billion. That would be more than double the company's latest private valuation of about $965 billion following a $65 billion funding round earlier this year. Anthropic's rapid growth is one reason investors are willing to consider such eye-watering numbers, with its annualized revenue passing $65 billion by the end of July. But the company is now facing another major challenge after OpenAI released its GPT-6 Astra model earlier this month. Astra has quickly gained ground with businesses, prompting some investors to question whether Anthropic can maintain its position as a leading provider of AI tools for companies. Newly released data showed Astra accounting for about 13 percent of enterprise AI spending tracked by Ramp, compared with around eight percent for Anthropic's Claude Fable. Anthropic still has a larger reported annualized revenue run rate, however, at more than $65 billion compared with more than $40 billion for OpenAI in July. The company is therefore heading towards a potentially huge IPO while trying to prove that its growth can keep pace with an increasingly crowded AI market. That market is changing quickly, with cheaper open-source AI systems giving businesses more alternatives and some large customers developing their own technology. The debate has also become political, with President Donald Trump pushing back against calls to slow AI development and introduce tougher guardrails Coxon's comments went viral, attracting more than 100 million views, and added to growing questions over whether the industry is moving faster than its safety measures can keep up Meta, one of Anthropic's biggest customers, is also looking to reduce its use of the company's AI models as it develops more technology in-house, according to people familiar with the matter. Anthropic is also considering releasing another AI model before its IPO in a bid to counter the growing momentum behind OpenAI's Astra, according to three people familiar with the matter. The company is weighing the safety of that next model as part of the decision, while investors will also be watching how much money Anthropic has to spend on the computer power needed to train and run its AI systems. The company has struck major deals with technology giants including Amazon and Google, making those relationships an important part of its financial picture. Anthropic is also expanding beyond its best-known chatbot, Claude, with work involving science, physical devices and drug research. It was revealed last week that the company has quietly established a biology laboratory in the San Francisco Bay Area to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. The move shows how AI companies are increasingly searching for lucrative uses beyond chatbots and computer coding. Anthropic co-founder Jack Clark has gone even further, saying AI companies need common safety standards and outside scrutiny as they race to develop more powerful systems That expansion is likely to attract plenty of attention from potential shareholders, particularly because Anthropic's enormous valuation depends on expectations that its business will continue growing rapidly. For ordinary investors, the biggest question will ultimately be whether the company can turn its huge revenue growth into a business that produces sustainable profits rather than simply spending more money to stay ahead. And with a possible $2 trillion valuation on the table, Anthropic's eventual IPO could become one of the clearest tests yet of just how much Wall Street is willing to pay for the AI boom. The Daily Mail has reached out to Anthropic for comment around the IPO delay and is awaiting a response.